Attwell announces shareholder approval of distribution of capital and 2009
annual results

TORONTO, March 26 /CNW/ - Attwell Capital Inc. (TSXV: AT.H) ("Attwell" or the "Company") announced today its shareholders have voted and unanimously approved a special resolution to reduce the stated capital of the Company's common shares by approximately $1.43M (the "Reduction of Stated Capital") and to provide a return of capital in the amount of $0.08 cash per common share to shareholders (the "Return of Capital"). In compliance with the policies of the TSX Venture Exchange, shareholders of record as at the close of business on April 7, 2010 will be entitled to the Return of Capital. It is expected that the cash distribution of $0.08 per share will be paid to such shareholders by April 13, 2010.

The Company also announced its financial results for the year ended December 31, 2009.

Attwell was created on March 27, 2009 to acquire certain assets and all liabilities of Fralex Therapeutics Inc. ("Fralex"), a medical technology company.

Operating highlights for 2009

    -   June 1, 2009, Fralex, Attwell, and Baylis Medical Inc. ("Baylis"), a
        privately-owned developer and supplier of medical devices, completed
        a plan of arrangement (the "Arrangement") whereby, among other
        things, Attwell acquired certain assets and assumed all liabilities
        of Fralex. Pursuant to the Arrangement, Fralex shareholders exchanged
        their shares for common shares of Attwell and Baylis acquired all of
        the issued and outstanding common shares of Fralex from Attwell in
        consideration for net proceeds of approximately $650,000 (gross
        proceeds of $900,000 less estimated transaction costs of $250,000);

    -   June 3, 2009 listing of the Company on NEX;

    -   Management continued to review opportunities to find a purchaser for
        the sale of the company; and

    -   Attwell had $1,621,906 in cash and short-term investments, and
        working capital of $1,807,413, as at December 31, 2009.

    Events subsequent to year end

    -   On February 16, 2010, the Board determined that the preferred method
        of distributing cash to shareholders would be pursuant to a reduction
        of the stated capital of its common shares and to provide a return of
        capital cash distribution in the amount of $0.08 per share; and

    -   On March 25, 2010, at a Special Meeting of Shareholders, shareholders
        authorized the Reduction of Stated Capital and Return of Capital as
        recommended by the Board.

"We are pleased to be able to return $1.43 million to the shareholders and continue to focus on executing a sale of our public entity", said Avi Grewal, President and CEO of Attwell.

Financial review

For the year ended December 31, 2009, the Company reported a decrease in loss of $4,545,695 as compared with the same period in 2008 due to the reduction in research and development costs of $3,811,223 resulting from the October 2008 termination of the RELIEF trial and the $900,000 gain on sale of assets pursuant to the Arrangement.

Additional information relating to the Company, including detailed financial statements and the MD&A related thereto, can be found on SEDAR at under Attwell Capital Inc.'s company profile (in respect of documents filed on or after June 2, 2009) and under Fralex Therapeutics Inc.'s company profile (in respect of documents filed up to and including June 1, 2009).

A full description of the terms of the Arrangement is provided in the information circular of Fralex dated April 22, 2009, which is available on SEDAR at under Fralex Therapeutics Inc.'s company profile.

A full description of the Reduction of Stated Capital and Return of Capital is provided in the information circular of Attwell dated February 22, 2010, which is available on SEDAR at under the Company's profile.

Certain statements contained in this release containing words like "believe", "intend", "may", "expect", and other similar expressions, are forward-looking statements and include statements relating to sale of the public entity and returning the cash to shareholders, the Company's future financial position, the continued listing of the Company's common shares on the NEX and the nature of the Company's business and operations following the Reduction of Stated Capital and Return of Capital. Such are based on assumptions, estimates, opinions and analysis made by Management in light of its experience, current conditions and its expectations of future developments as well as other factors it believes to be reasonable and relevant. These assumptions include, but are not limited to, those concerning the ability to identify a purchaser for the sale of the Company. Forward-looking statements involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the Company's forward-looking statements include the following: legal product liability and availability of insurance; risks related to the arrangement including but not limited to post-arrangement tax indemnification of the Company and Baylis; difficulties in identifying an interested party to purchase Attwell, the uncertainty inherent in attracting capital, dependence on key personnel and other risk factors identified from time to time in the Company's filings. The forward-looking statements contained in this release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements contained herein or in any other document filed with securities regulatory authorities, except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.

    Attwell Capital Inc.
    Balance Sheets

                                                      December      December
                                                      31, 2009      31, 2008
                                                             $             $

    Current assets
    Cash                                                70,689       184,064
    Short-term investments                           1,551,217     3,566,280
    Investment tax credits receivable                  232,944       290,000
    Receivables - other                                 10,382        35,089
    Prepaid expenses and deposits                       17,733        31,563
                                                     1,882,965     4,106,996

    Property and equipment                               2,648        35,579

                                                     1,885,613     4,142,575


    Current liabilities
    Accounts payable and accrued liabilities            75,552     1,356,096

    Shareholders' equity

    Share capital                                   15,292,513    18,030,787
    Warrants                                                 -     1,064,777
    Other equity                                     4,340,944       584,068
    Deficit                                        (17,823,396)  (17,078,991)
    Accumulated other comprehensive income                   -       185,838

                                                     1,810,061     2,786,479

                                                     1,885,613     4,142,575

    Attwell Capital Inc.
    Statements of Operations and Comprehensive Loss

                                                      Year ended December 31,

                                                          2009          2008
                                                             $             $

    Research and development                           325,519     4,136,742
    General and administrative                       1,465,041     1,336,838
    Stock-based compensation                           183,963       192,888
    Amortization                                        14,454        48,243
    Write-down of property and equipment                17,502             -
    Foreign exchange gain                             (170,143)     (228,647)

    Loss before the undernoted                       1,836,336     5,486,064

    Interest income - net                              (13,581)     (194,964)

    Gain on sale of assets                            (900,000)            -

    Loss before income taxes                           922,755     5,291,100

    Income tax recovery                               (178,350)            -

    Net loss for the year                              744,405     5,291,100
    Other comprehensive loss (income)

    Reclassification adjustment for foreign
     exchange gains included in net loss               185,838             -

    Unrealized foreign exchange gain on
     available-for-sale short-term investments               -      (187,902)

    Comprehensive loss for the year                    930,243     5,103,198

    Basic and diluted loss per common share              (0.04)        (0.24)


For further information: For further information: Avi Grewal, President and Chief Executive Officer, Attwell Capital Inc., (416) 213-8118 ext. 210,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890